Bio-Rad Laboratories Newsroom

Whole Genome Sequencing Market Report 2024-2034: Key Player Profiles for Agilent Technologies, BGI Group, Bio-Rad Laboratories, Eurofins Scientific, Illumina, Thermo Fisher Scientific & ProPhase Labs - ResearchAndMarkets.com

BusinesswireDec 17 12:42 ET

India Microfluidics Market Report 2024, With Profiles of AQC Chem. Lab, Bio-Rad Laboratories India, Abbott India, PerkinElmer India and Thermo Fisher Scientific India

Yahoo FinanceDec 11 04:08 ET

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $481

Moomoo NewsDec 9 07:33 ET · Ratings

Bio-Rad Laboratories Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk

Dow JonesNov 15 12:13 ET

What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?

Yahoo FinanceNov 13 08:46 ET

Calculating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)

Simply Wall StNov 12 05:45 ET

Express News | CORRECTION: Bioage Labs Ticker Is "BIOA"

BenzingaNov 4 09:04 ET

Express News | BioAge Labs To Present New Preclinical Data For Lead Product Candidate Azelapragor At ObesityWeek 2024

BenzingaNov 4 09:02 ET

Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Yahoo FinanceNov 2 08:23 ET

Express News | Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450

BenzingaNov 1 15:21 ET

Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.

BenzingaNov 1 15:21 ET

Express News | NYSE Halt Bio-Rad Labs B Add Info Lst $334.850000

ReutersNov 1 11:44 ET

A Quick Look at Today's Ratings for Bio-Rad Laboratories(BIO.US), With a Forecast Between $360 to $469

Moomoo NewsNov 1 09:00 ET · Ratings

Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (Vs US$3.65 in 3Q 2023)

Yahoo FinanceNov 1 06:43 ET

Bio-Rad Labs Misses Q3 Estimates for Profit, Revenue

Seeking AlphaNov 1 02:39 ET

Bio-Rad Laboratories | 10-Q: Q3 2024 Earnings Report

SECOct 31 16:23 ET · Announcements

Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital

Dow JonesOct 31 15:49 ET · Ratings

Bio-Rad Laboratories Analyst Ratings

BenzingaOct 31 15:38 ET · Ratings

Bio-Rad Laboratories Up Over 5%, On Track for Largest Percent Increase Since December 2023 -- Data Talk

Dow JonesOct 31 13:03 ET

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

BusinesswireOct 31 09:00 ET